Challenges to Cell Expansion for Allogenic Cell Therapies: Sourcing of donor cells, access to fit-for-purpose reagents and manufacturing systems, and scalability are top issues.
| Publicado en: | BioPharm International Vol. 36; no. 8; pp. 22 - 26 |
|---|---|
| Autor principal: | |
| Formato: | pictorial Journal Article |
| Publicado: |
MJH Life Sciences
Aug2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=169801649&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 169801649 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 1542166X 5NE jtl: BioPharm International issn: 1542166X maglogo: N pubinfo: dt: Aug2023 vid: 36 iid: 8 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 169801649 169801649 169801649 169801649 ppf: 22 ppct: 4 formats: fmt: @attributes: type: P tig: atl: Challenges to Cell Expansion for Allogenic Cell Therapies: Sourcing of donor cells, access to fit-for-purpose reagents and manufacturing systems, and scalability are top issues. aug: au: CHALLENER, CYNTHIA A. affil: PhD is a contributing editor to BioPharm International sug: subj: Cell Proliferation Allogeneic Cells Cell Therapy Bone Marrow Transplantation Indicators and Reagents Killer Cells, Natural Cryopreservation T Lymphocytes Biological Products pubtype: Trade Publication doctype: pictorial Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|